There are multiple published series of Avastin for AMD that demonstrate an anatomic and visual effect similar to that seen with Lucentis; however, most of these studies are short term, retrospective, uncontrolled and lack the standardized vision measurements and safety reporting required in FDA trials.3-9 Theoretically, the significantly longer serum half-life of Avastin compared to Lucentis could